🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jamie Goldman

Oracle (United States)

ORCID: 0000-0001-8986-3555

Also affiliated with St Michael's Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report”.

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report

Journal of Medical Case Reports(2021)10.1186/s13256-020-02637-w

N/A

0.165DataRank · unranked

2 citations

Dylan J. Martini, Sean T. Evans, Jamie Goldman, Mehmet Asım Bilen, T. Anders Olsen

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2

N/A

0.104DataRank · unranked

1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345

N/A

0DataRank · unranked

9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868

N/A

0DataRank · unranked

43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Phase II trial of opaganib in patients with metastatic castration-resistant prostate cancer progressing on abiraterone or enzalutamide (NCT04207255).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps191

N/A

0DataRank · unranked

3 citations

Charles D. Smith, Terry F. Plasse, Besim Öğretmen, Shikhar Mehrotra, Theodore Stewart Gourdin +6 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393

N/A

0DataRank · unranked

4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922

N/A

0DataRank · unranked

32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more